Skip to main content

Winton Group Ltd

SEC CIK
0001612063
Latest filing
Aug 7, 2026

PLX holding history

Protalix BioTherapeutics, Inc. in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PLX overviewAll 13F holders of PLXFull Q2 2026 holdings

Shares (Q2 2026)
56,001
Value
$130.5K
% of portfolio
<0.1%
Quarters held
1
Since Q2 2026
Holdings of PLX by Winton Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202656,001$130.5K<0.1%+56,001NewHolders